EBITDA's not as impressive as the NPAT, which is unusual... the R&D Tax Credit of about $6m means we have $9.3m NPAT, but only $3.7m EBITDA.
The maiden profit is a little more tempered with that info, but still, none of us are buying for the 2023 profit. The growth potential is excellent. Would've loved a projected FY24 somewhere in there.
Ann: February 2024 Investor Presentation, page-7
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DRO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.008(0.51%) |
Mkt cap ! $1.103B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.50 | $1.41 | $18.49M | 12.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 114664 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 74707 | 16 |
View Market Depth
| Last trade - 15.43pm 25/07/2024 (20 minute delay) ? |
| DRO (ASX) Chart |